Financial reports
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
9 Mar 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
22 Mar 22
10-K/A
2021 FY
Annual report (amended)
30 Dec 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
12 Mar 24
8-K
Cost Associated with Exit or Disposal Activities
9 Feb 24
8-K
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
29 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Dec 23
8-K
Material Modifications to Rights of Security Holders
5 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
29 Nov 23
8-K
Science 37 Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Science 37 Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Jun 23
8-K
Science 37 Reports First Quarter 2023 Financial Results
15 May 23
Registration and prospectus
15-12G
Securities registration termination
22 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
POS AM
Prospectus update (post-effective amendment)
12 Mar 24
POS AM
Prospectus update (post-effective amendment)
12 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
12 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
12 Mar 24
25-NSE
Exchange delisting
12 Mar 24
Other
EFFECT
Notice of effectiveness
15 Mar 24
EFFECT
Notice of effectiveness
15 Mar 24
EFFECT
Notice of effectiveness
14 Mar 23
CORRESP
Correspondence with SEC
10 Mar 23
UPLOAD
Letter from SEC
10 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
CORRESP
Correspondence with SEC
6 Mar 23
EFFECT
Notice of effectiveness
21 Apr 22
EFFECT
Notice of effectiveness
26 Jan 22
CORRESP
Correspondence with SEC
21 Jan 22
Ownership
4
Change in insider ownership
14 Mar 24
4
Change in insider ownership
14 Mar 24
3/A
Initial statement of insider ownership (amended)
14 Mar 24
SC 13D/A
THERMO FISHER SCIENTIFIC INC.
14 Mar 24
4
Robert C. Faulkner
13 Mar 24
4
Jeremy Green
13 Mar 24
SC 13D/A
Redmile Group, LLC
13 Mar 24
4
Michael Shipton
12 Mar 24
4
Jonathan Cotliar
12 Mar 24
4
Darcy Forman
12 Mar 24